Drreddys Laboratories reported INR17.29B in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ani Pharmaceuticals ANIP:US USD 286.73M 213K
Aurora Cannabis Inc ACB:CN CAD 325.57M 56.08M
Bayer BAYN:GR EUR 44.79B 157M
Canopy Growth Corp WEED:CN CAD 1.48B 111.05M
Catalent CTLT:US USD 4.2B 2M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Hikma Pharmaceutical HIK:LN USD 1.55B 705M
Horizon Pharma HZNP:US USD 2.57B 1.85M
Lannett LCI:US USD 619.34M 4.39M
Lonza Group LONN:SW CHF 2.23B 171M
Novartis NOVN:VX USD 28.44B 2.59B
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Phibro Animal Health PAHC:US USD 467.16M 34.23M
Prestige Brands PBH:US USD 1.44B 34.77M
Richter Gedeon RICHT:HB HUF 17.49B 2.48B
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Teva Pharmaceutical TEVA:IT USD 21.27B 816M